- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04750694
High Intensity Resistance Training Combined With Blood Flow Restricted Exercise in Elite Handball Players
Purpose of the study is: to investigate the effects of 8 weeks intervention of high intensity resistance training(HIRT) combined with Blood Flow Restricted Exercise (BFRE) compared to high intensity resistance training alone.
Detailed Description: 30 elite handball players will be randomized into 2 groups of 15 participants each. Participants will be evaluated in the week before and the week after an 8-weeks training intervention with 2 weekly sessions. Based on their baseline muscle strength the participants will be randomized into two groups: HIRT-BFRE or HIRT-HIRT. Participants in both groups will perform a full-body training programme of HIRT. After the Full-body programme, Back squat exercise with low intensity and Blood flow restriction will be performed to the HIRT-BFRE group and back squat exercise with high intensity without blood flow restriction will be performed by HIRT-HIRT. Evaluation protocol includes: muscle strength measurement with 1 repetition maximum of Back squat and knee extension, muscle mass with Dual-Energy X-ray absorptiometry, muscle thickness of the thigh with ultra sound measurement, vertical jump height with linear Encoder, sprint performance with 30m sprint time.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Recruiting
- Dept. of Public Health
-
Contact:
- Simon Lønbro, PhD
- Phone Number: 21600410
- Email: loenbro@ph.au.dk
-
Contact:
- Esben Madsen, MSc student
-
Sub-Investigator:
- Mikkel Garbrecht, MSc student
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age >= 18 years
- Ds
- Minimum of 2 years of resistance training experience
- >< Two resistance training sessions each week
- >< three handball sessions each week
- No injuries that prevent participants to perform test of maximal muscle strength
- No injuries, that affects the muscle strength or the ability to train
Exclusion Criteria:
- Elevated blood pressure (>140/90)
- Anabolic steroids or prescription-only medical products with know or potential effect on muscle hypertrophy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: RT + BFRE
High intensity Resistance training combined with Blood Flow
|
A full-training programme with high intensity followed by back squat exercise with blood flow restriction.
Inflatable cuffs will be placed proximally on both thighs.
The cuff pressure will be 50% of individual arterial occlusion pressure and will be maintained during the rest intervals.
Participants will perform 30, 15, 15 and 15 repetitions of 30% of 1 Repetition Maximum.
Totally 75 repetitions will be performed.
45 seconds rest interval between sets will be given.
|
Active Comparator: RT
Resistance training alone
|
A full-training programme with high intensity followed by back squat exercise with blood flow restriction.
Inflatable cuffs will be placed proximally on both thighs.
The cuff pressure will be 50% of individual arterial occlusion pressure and will be maintained during the rest intervals.
Participants will perform 30, 15, 15 and 15 repetitions of 30% of 1 Repetition Maximum.
Totally 75 repetitions will be performed.
45 seconds rest interval between sets will be given.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Maximal Muscle Strength
Time Frame: Baseline measurements at week 1, after four weeks of exercise at week 5 and post intervention at week 10.
|
Change in 1 RM (repetition maximum) muscle strength in back squat
|
Baseline measurements at week 1, after four weeks of exercise at week 5 and post intervention at week 10.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Lean body mass
Time Frame: Baseline measurements at week 1 and post intervention at week 10.
|
Change in lean body mass assessed by Dual Energy X-ray Absorptiometry
|
Baseline measurements at week 1 and post intervention at week 10.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Jump Performance
Time Frame: Baseline measurements at week 1 and post intervention at week 10.
|
Change in jump height.
Change in vertical jump height (in cm, with Chronojump Linear Encoder Kit).
Participants will perform a counter movement jump and jump as high as possible.
The jump height will be recorded.
|
Baseline measurements at week 1 and post intervention at week 10.
|
Sprint performance
Time Frame: Baseline measurements at week 1 and post intervention at week 10.
|
Sprint performance.
Change in sprint time (in seconds, with Witt speed gates).
Participant will perform a 30-meter sprint on an indoor handball court.
The time to perform a 30-meter sprint will be recorded.
|
Baseline measurements at week 1 and post intervention at week 10.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VEK ID 74646
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertrophy
-
Rhode Island HospitalCompletedChildren, Only | Tonsillar Hypertrophy | Adenoid HypertrophyUnited States
-
Olubukola NafiuNot yet recruitingSurgery | Tonsillar Hypertrophy | Adenoid Hypertrophy
-
Nagoya UniversityUnknownHypertensive Left Ventricular HypertrophyJapan
-
Istanbul UniversityWithdrawn
-
Organon and CoCompleted
-
Seoul National University HospitalSamsung Medical Center; Chung-Ang University Hosptial, Chung-Ang University... and other collaboratorsCompletedTonsillar HypertrophyKorea, Republic of
-
Marymount UniversityUniversity of TehranCompleted
-
Mansoura UniversityCompleted
-
Marmara UniversityCompletedFrenulum; Hypertrophy, Lip
-
Assistance Publique - Hôpitaux de ParisInstitute of Cardiometabolism and Nutrition, FranceNot yet recruitingLeft Ventricular HypertrophyFrance
Clinical Trials on Resistance training
-
University of KasselCompleted
-
University of KasselUniversity of PotsdamCompleted
-
University of Alabama at BirminghamCompletedMusculoskeletal and Metabolic CrosstalkUnited States
-
University of Applied Sciences of Western SwitzerlandCompleted
-
Vienna Hospital AssociationCompleted
-
University of BarcelonaCompleted
-
Universidade Federal de Sao CarlosConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Hong Kong Metropolitan UniversityRecruitingFrailty | Mood | Cognition | Mobility | SacropeniaHong Kong
-
Universidade Federal do Triangulo MineiroUnknown
-
Riphah International UniversityCompletedSports Physical Therapy | Anthropometric Measurements and Elastic Resistance TrainingPakistan